Literature DB >> 11470230

Human endothelial gelatinases and angiogenesis.

M Nguyen1, J Arkell, C J Jackson.   

Abstract

Endothelial cell invasion is an essential event during angiogenesis (formation of new blood vessels). The process involves the degradation of the basement membrane and the underlying interstitium. The matrix metalloproteinase (MMP) family is considered to be primarily responsible for matrix degradation. Two members of the family, gelatinase A and B play an important role in angiogenesis. This review outlines recent findings on their regulation in human endothelial cells. Latent gelatinase B is secreted from endothelial cells. This enzyme can also accumulate in the cytosol as an active enzyme, free of TIMP-1. In contrast, latent gelatinase A is constitutively secreted from the cells. Unlike other MMPs, gelatinase A activation occurs on the cell membrane and is mediated by MT1-MMP. A number of physiological activators have recently been described. These include thrombin and activated protein C, both of which activate gelatinase A independent of the MT1-MMP pathway. These new findings may lead to therapeutic interventions for the treatment of angiogenic-dependent diseases such as cancer and arthritis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11470230     DOI: 10.1016/s1357-2725(01)00007-3

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  63 in total

Review 1.  Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.

Authors:  Klaus Maskos; Wolfram Bode
Journal:  Mol Biotechnol       Date:  2003-11       Impact factor: 2.695

2.  Vasculogenesis and Angiogenesis: Molecular and Cellular Controls. Part 2: Interactions between Cell and Extracellular Environment.

Authors:  N Kubis; B I Levy
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

Review 3.  An in-silico future for the engineering of functional tissues and organs.

Authors:  Vanessa Díaz-Zuccarini; Pat V Lawford
Journal:  Organogenesis       Date:  2010 Oct-Dec       Impact factor: 2.500

4.  Biocompatibility studies of low temperature nitrided and collagen-I coated AISI 316L austenitic stainless steel.

Authors:  M Martinesi; M Stio; C Treves; F Borgioli
Journal:  J Mater Sci Mater Med       Date:  2013-03-08       Impact factor: 3.896

5.  Inhibitory effect of Aspergillus fumigatus extract on matrix metalloproteinases expression.

Authors:  Farshid Saadat; Kamiar Zomorodian; Mohammad Pezeshki; Sassan Rezaie; Mohammad Reza Khorramizadeh
Journal:  Mycopathologia       Date:  2004-07       Impact factor: 2.574

Review 6.  Matrix metalloproteinase-9 and autoimmune diseases.

Authors:  Maya Ram; Yaniv Sherer; Yehuda Shoenfeld
Journal:  J Clin Immunol       Date:  2006-05-02       Impact factor: 8.317

7.  Expression of matrix metalloproteinases-2 and -9 and RECK during alveolar bone regeneration in rat.

Authors:  Thais Accorsi-Mendonça; Katiúcia Batista da Silva Paiva; Willian Fernando Zambuzzi; Tânia Mary Cestari; Vanessa Soares Lara; Mari Cleide Sogayar; Rumio Taga; José Mauro Granjeiro
Journal:  J Mol Histol       Date:  2007-11-07       Impact factor: 2.611

8.  Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo.

Authors:  Quteba Ebrahem; Shyam S Chaurasia; Amit Vasanji; Jian Hua Qi; Phillip A Klenotic; Alecia Cutler; Kewal Asosingh; Serpil Erzurum; Bela Anand-Apte
Journal:  Am J Pathol       Date:  2009-11-30       Impact factor: 4.307

9.  Matrix metalloproteinase-2 is elevated in midtrimester amniotic fluid prior to the development of preeclampsia.

Authors:  Michal Lavee; Shlomit Goldman; Etty Daniel-Spiegel; Eliezer Shalev
Journal:  Reprod Biol Endocrinol       Date:  2009-08-23       Impact factor: 5.211

10.  Functional and transcriptional characterization of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction.

Authors:  Zongjin Li; Kitchener D Wilson; Bryan Smith; Daniel L Kraft; Fangjun Jia; Mei Huang; Xiaoyan Xie; Robert C Robbins; Sanjiv S Gambhir; Irving L Weissman; Joseph C Wu
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.